Medical Episode Grouper - Health Plan

Medical Episode Grouper® (MEG) from Truven Health enables health plans to analyze patient treatments, evaluate quality of care, and manage associated costs. Plans can incorporate MEG into their existing information system, or it can serve as an integrated component of Advantage Suite®.

The Cornerstone for Accurate Healthcare Analysis

MEG is a widely accepted episode methodology that is used by payers analyzing over 43 million covered lives. Since its inception in 1998, MEG has been continually improved and is a trusted resource for its ability to accurately measure physician performance, improve quality, and reduce costs.

Physicians identify with a methodology that is based on clinical models and find the MEG risk adjustments credible.

Founded upon 25 years of clinical expertise, MEG makes accurate physician evaluation possible and enables plans to evaluate quality of care.

Only MEG has a patent-pending, patient severity based risk-adjustment methodology which results in greater explanatory power. MEG is based upon the fifth edition Disease Staging® patient classification system with more than 570 disease categories further stratified by severity level — enabling a sophisticated understanding of conditions, disease progression and care choices. To keep up with the latest advances in medicine, Truven Health assembled a distinguished panel of experts including over 50 physician specialists, and every disease category was reviewed by at least three physicians. With this level of discipline and continuous improvement, you can be confident that MEG delivers better information and better results.

  • Clinically defined measures that physicians find credible, enabling physician engagement and collaboration
  • Ability to review severity stratified data and assess the appropriateness of procedures with a clinically sound basis to improve quality
  • Builds episodes based on the clinical diagnosis of the patient’s illness to allow a fair evaluation of treatment appropriateness that will lead to the avoidance of unnecessary medical interventions and reduced costs
  • Identifies high-risk patients for disease / care management programs to improve the clinical basis for patient selection and target the right patients for the right programs
  • Allows for evaluation of disease / care management programs on a risk-adjusted basis to gain a more accurate reflection of ROI for your disease / care management programs